XELJANZ® 5 mg


film‑coated tablets
scheduling status
S4
registration number
47/3.1/1156
What XELJANZ® 5 mg contains
Tofacitinib.
other ingredients
Tablet core Croscarmellose sodium Lactose monohydrate Magnesium stearate Microcrystalline cellulose Film coating Hypromellose Lactose monohydrate Macrogol 3350 Titanium dioxide Triacetin FD&C Blue #2 / Indigo Carmine Aluminium Lake (10 mg only) FD&C Blue #1 / Brilliant Blue FCF Aluminium Lake (10 mg only).
Therapeutic classification
L04AA29 - Immunosuppressants – Selective immunosuppressants (Tofacitinib).
© 2026 SAHPRA. ALL RIGHTS RESERVED